<DOC>
	<DOCNO>NCT02405780</DOCNO>
	<brief_summary>The purpose study compare safety , effectiveness immunogenicity FKB327 comparison Humira® rheumatoid arthritis patient complete study FKB327-002 inadequate disease control methotrexate .</brief_summary>
	<brief_title>A Study Compare FKB327 Long-term Safety , Efficacy Immunogenicity With Humira® Rheumatoid Arthritis Patients</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>1 . Patient complete Week 24 visit procedure Study FKB327002 continue methotrexate 2 . In investigator 's opinion , patient show clinical response treatment Study FKB327002 1 . Patient evidence serious adverse event ( SAE ) ongoing Study FKB327002 2 . Patient presence active and/or untreated latent tuberculosis ( TB ) Other Inclusion/Exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Rheumatoid</keyword>
	<keyword>Arthritis</keyword>
</DOC>